In line, we found that SARS-CoV-2-specific CD8+ T cells of LC patients with persistent symptoms 12 months after acute disease showed higher CD25 levels compared to convalescent individuals. This evidence concerns the gene CD8A and laryngotracheoesophageal cleft.